Psychedelics promote plasticity by directly binding to BDNF receptor TrkBстатья
Статья опубликована в высокорейтинговом журнале
Информация о цитировании статьи получена из
Scopus
Статья опубликована в журнале из списка Web of Science и/или Scopus
Дата последнего поиска статьи во внешних источниках: 1 января 2025 г.
Аннотация:Psychedelics produce fast and persistent antidepressant efects and
induce neuroplasticity resembling the efects of clinically approved
antidepressants. We recently reported that pharmacologically diverse
antidepressants, including fuoxetine and ketamine, act by binding to TrkB,
the receptor for BDNF. Here we show that lysergic acid diethylamide (LSD)
and psilocin directly bind to TrkB with afnities 1,000-fold higher than those
for other antidepressants, and that psychedelics and antidepressants bind
to distinct but partially overlapping sites within the transmembrane domain
of TrkB dimers. The efects of psychedelics on neurotrophic signaling,
plasticity and antidepressant-like behavior in mice depend on TrkB binding
and promotion of endogenous BDNF signaling but are independent of
serotonin 2A receptor (5-HT2A) activation, whereas LSD-induced head
twitching is dependent on 5-HT2A and independent of TrkB binding. Our
data confrm TrkB as a common primary target for antidepressants and
suggest that high-afnity TrkB positive allosteric modulators lacking 5-HT2A
activity may retain the antidepressant potential of psychedelics without
hallucinogenic efects.